|
1
|
Fares N and Pèron JM: Epidemiology,
natural history and risk factors of hepatocellular carcinoma. Rev
Prat. 63:216–217. 2013.In French.
|
|
2
|
Huitzil-Melendez FD, Capanu M, O'Reilly
EM, Duffy A, Gansukh B, Saltz LL and Abou-Alfa GK: Advanced
hepatocellular carcinoma: Which staging systems best predict
prognosis? J Clin Oncol. 28:2889–2895. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Zou C, Li Y, Cao Y, Zhang J, Jiang J,
Sheng Y, Wang S, Huang A and Tang H: Up-regulated MicroRNA-181a
induces carcinogenesis in hepatitis B virus-related hepatocellular
carcinoma by targeting E2F5. BMC Cancer. 14:972014. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Giordano S and Columbano A: MicroRNAs: New
tools for diagnosis, prognosis and therapy in hepatocellular
carcinoma? Hepatology. 57:840–847. 2013. View Article : Google Scholar
|
|
5
|
El-Serag HB: Epidemiology of viral
hepatitis and hepatocellular carcinoma. Gastroenterology.
142:1264–1273. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Sanyal AJ, Yoon SK and Lencioni R: The
etiology of hepatocellular carcinoma and consequences for
treatment. Oncologist. 15(Suppl 4): S14–S22. 2010. View Article : Google Scholar
|
|
7
|
Rahbari NN, Mehrabi A, Mollberg NM, Muller
SA, Koch M, Buchler MW and Weitz J: Hepatocellular carcinoma:
Current management and perspectives for the future. Ann Surg.
253:453–469. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Worns MA and Galle PR: Future perspectives
in hepatocellular carcinoma. Dig Liver Dis. 42(Suppl 3): S302–S309.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Portolani N, Coniglio A, Ghidoni S,
Giovanelli M, Benetti A, Tiberio GA and Giulini SM: Early and late
recurrence after liver resection for hepatocellular carcinoma:
Prognostic and therapeutic implications. Ann Surg. 243:229–235.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Thorgeirsson SS, Lee JS and Grisham JW:
Functional genomics of hepatocellular carcinoma. Hepatology. 43(2
Suppl 1): S145–S150. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Villanueva A, Newell P, Chiang DY,
Friedman SL and Llovet JM: Genomics and signaling pathways in
hepatocellular carcinoma. Semin Liver Dis. 27:55–76. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Wang MJ, Li Y, Wang R, Yu YY, Yang L,
Zhang Y, Zhou B, Zhou ZG and Sun XF: Downregulation of microRNA-124
is an independent prognostic factor in patients with colorectal
cancer. Int J Colorectal Dis. 28:183–189. 2013. View Article : Google Scholar
|
|
13
|
Lewis BP, Burge CB and Bartel DP:
Conserved seed pairing, often flanked by adenosines, indicates that
thousands of human genes are microRNA targets. Cell. 120:15–20.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Deng X, Ma L, Wu M, Zhang G, Jin C, Guo Y
and Liu R: miR-124 radiosensitizes human glioma cells by targeting
CDK4. J Neurooncol. 114:263–274. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Vecchione A, Belletti B, Lovat F, Volinia
S, Chiappetta G, Giglio S, Sonego M, Cirombella R, Onesti EC,
Pellegrini P, et al: A microRNA signature defines chemoresistance
in ovarian cancer through modulation of angiogenesis. Proc Natl
Acad Sci USA. 110:9845–9850. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Aigner A: MicroRNAs (miRNAs) in cancer
invasion and metastasis: Therapeutic approaches based on
metastasis-related miRNAs. J Mol Med (Berl). 89:445–457. 2011.
View Article : Google Scholar
|
|
17
|
Farazi TA, Hoell JI, Morozov P and Tuschl
T: MicroRNAs in human cancer. Adv Exp Med Biol. 774:1–20. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Di Leva G and Croce CM: The Role of
microRNAs in the tumorigenesis of ovarian cancer. Front Oncol.
3:1532013. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Fang L, Deng Z, Shatseva T, Yang J, Peng
C, Du WW, Yee AJ, Ang LC, He C, Shan SW and Yang BB: MicroRNA
miR-93 promotes tumor growth and angiogenesis by targeting
integrin-β8. Oncogene. 30:806–821. 2011. View Article : Google Scholar
|
|
20
|
Su Y, Li X, Ji W, Sun B, Xu C, Li Z, Qian
G and Su C: Small molecule with big role: MicroRNAs in cancer
metastatic micro-environments. Cancer Lett. 344:147–156. 2014.
View Article : Google Scholar
|
|
21
|
Garzon R, Calin GA and Croce CM: MicroRNAs
in cancer. Annu Rev Med. 60:167–179. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Zhang Z, Zheng W and Hai J: MicroRNA-148b
expression is decreased in hepatocellular carcinoma and associated
with prognosis. Med Oncol. 31:9842014. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Bartel DP: MicroRNAs: Genomics,
biogenesis, mechanism and function. Cell. 116:281–297. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Schwabe RF and Wang TC: Targeting liver
cancer: First steps toward a miRacle? Cancer Cell. 20:698–699.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Iorio MV, Casalini P, Piovan C, Braccioli
L and Tagliabue E: Breast cancer and microRNAs: Therapeutic impact.
Breast. 20(Suppl 3): S63–S70. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Chen Y, Song Y, Wang Z, Yue Z, Xu H, Xing
C and Liu Z: Altered expression of MiR-148a and MiR-152 in
gastrointestinal cancers and its clinical significance. J
Gastrointest Surg. 14:1170–1179. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Chen Y, Song YX and Wang ZN: The
microRNA-148/152 family: Multi-faceted players. Mol Cancer.
12:432013. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Song Y, Xu Y, Wang Z, Chen Y, Yue Z, Gao
P, Xing C and Xu H: MicroRNA-148b suppresses cell growth by
targeting cholecystokinin-2 receptor in colorectal cancer. Int J
Cancer. 131:1042–1051. 2012. View Article : Google Scholar
|
|
29
|
Song YX, Yue ZY, Wang ZN, Xu YY, Luo Y, Xu
HM, Zhang X, Jiang L, Xing CZ and Zhang Y: MicroRNA-148b is
frequently downregulated in gastric cancer and acts as a tumor
suppressor by inhibiting cell proliferation. Mol Cancer. 10:12011.
View Article : Google Scholar
|
|
30
|
Bloomston M, Frankel WL, Petrocca F,
Volinia S, Alder H, Hagan JP, Liu CG, Bhatt D, Taccioli C and Croce
CM: MicroRNA expression patterns to differentiate pancreatic
adenocarcinoma from normal pancreas and chronic pancreatitis. JAMA.
297:1901–1908. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Schetter AJ, Leung SY, Sohn JJ, Zanetti
KA, Bowman ED, Yanaihara N, Yuen ST, Chan TL, Kwong DL, Au GK, et
al: MicroRNA expression profiles associated with prognosis and
therapeutic outcome in colon adenocarcinoma. JAMA. 299:425–436.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Yu T, Wang XY, Gong RG, Li A, Yang S, Cao
YT, Wen YM, Wang CM and Yi XZ: The expression profile of microRNAs
in a model of 7,12-dimethyl-benz[a]anthrance-induced oral
carcinogenesis in Syrian hamster. J Exp Clin Cancer Res. 28:642009.
View Article : Google Scholar
|
|
33
|
Cimino D, De Pittá C, Orso F, Zampini M,
Casara S, Penna E, Quaglino E, Forni M, Damasco C, Pinatel E, et
al: miR148b is a major coordinator of breast cancer progression in
a relapse-associated microRNA signature by targeting ITGA5, ROCK1,
PIK3CA, NRAS and CSF1. FASEB J. 27:1223–1235. 2013. View Article : Google Scholar
|
|
34
|
Wu Y, Liu GL, Liu SH, Wang CX, Xu YL, Ying
Y and Mao P: MicroRNA-148b enhances the radiosensitivity of
non-Hodgkin's lymphoma cells by promoting radiation-induced
apoptosis. J Radiat Res. 53:516–525. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Zheng B, Liang L, Wang C, Huang S, Cao X,
Zha R, Liu L, Jia D, Tian Q, Wu J, et al: MicroRNA-148a suppresses
tumor cell invasion and metastasis by downregulating ROCK1 in
gastric cancer. Clin Cancer Res. 17:7574–7583. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Nakagawa H, Yoshioka K, Miyahara E,
Fukushima Y, Tamura M and Itoh K: Intrathecal administration of
Y-27632, a specific rho-associated kinase inhibitor, for rat
neoplastic meningitis. Mol Cancer Res. 3:425–433. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Xue F, Takahara T, Yata Y, Xia Q, Nonome
K, Shinno E, Kanayama M, Takahara S and Sugiyama T: Blockade of
Rho/Rho-associated coiled coil-forming kinase signaling can prevent
progression of hepatocellular carcinoma in matrix
metal-loproteinase-dependent manner. Hepatol Res. 38:810–817. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Lane J, Martin TA, Watkins G, Mansel RE
and Jiang WG: The expression and prognostic value of ROCKI and
ROCKII and their role in human breast cancer. Int J Oncol.
33:585–593. 2008.PubMed/NCBI
|
|
39
|
Vishnubhotla R, Sun S, Huq J, Bulic M,
Ramesh A, Guzman G, Cho M and Glover SC: ROCK-II mediates colon
cancer invasion via regulation of MMP-2 and MMP-13 at the site of
invadopodia as revealed by multiphoton imaging. Lab Invest.
87:1149–1158. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Riento K and Ridley AJ: Rocks:
Multifunctional kinases in cell behaviour. Nat Rev Mol Cell Biol.
4:446–456. 2003. View
Article : Google Scholar : PubMed/NCBI
|
|
41
|
Nakagawa O, Fujisawa K, Ishizaki T, Saito
Y, Nakao K and Narumiya S: ROCK-I and ROCK-II, two isoforms of
Rho-associated coiled-coil forming protein serine/threonine kinase
in mice. FEBS Lett. 392:189–193. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Lock FE, Ryan KR, Poulter NS, Parsons M
and Hotchin NA: Differential regulation of adhesion complex
turnover by ROCK1 and ROCK2. PLoS One. 7:e314232012. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Zhou X, Wei M and Wang W: MicroRNA-340
suppresses osteosarcoma tumor growth and metastasis by directly
targeting ROCK1. Biochem Biophys Res Commun. 437:653–658. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Ma W, Wong CC, Tung EK, Wong CM and Ng IO:
RhoE is frequently downregulated in hepatocellular carcinoma (HCC)
and suppresses HCC invasion through antagonizing the
Rho/Rho-kinase/myosin phosphatase target pathway. Hepatology.
57:152–161. 2013. View Article : Google Scholar
|
|
45
|
An L, Liu Y, Wu A and Guan Y: microRNA-124
inhibits migration and invasion by down-regulating ROCK1 in glioma.
PLoS One. 8:e694782013. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Xu X, Li S, Lin Y, Chen H, Hu Z, Mao Y, Xu
X, Wu J, Zhu Y, Zheng X, et al: MicroRNA-124-3p inhibits cell
migration and invasion in bladder cancer cells by targeting ROCK1.
J Transl Med. 11:2762013. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Ueno K, Hirata H, Shahryari V, Chen Y,
Zaman MS, Singh K, Tabatabai ZL, Hinoda Y and Dahiya R: Tumour
suppressor microRNA-584 directly targets oncogene Rock-1 and
decreases invasion ability in human clear cell renal cell
carcinoma. Br J Cancer. 104:308–315. 2011. View Article : Google Scholar :
|
|
48
|
Lynch J, Fay J, Meehan M, Bryan K, Watters
KM, Murphy DM and Stallings RL: MiRNA-335 suppresses neuroblastoma
cell invasiveness by direct targeting of multiple genes from the
non-canonical TGF-β signalling pathway. Carcinogenesis. 33:976–985.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Lin SL, Chiang A, Chang D and Ying SY:
Loss of mir-146a function in hormone-refractory prostate cancer.
RNA. 14:417–424. 2008. View Article : Google Scholar : PubMed/NCBI
|
